An estimated one in every four people in China suffers from cardiovascular disease. Among them are patients with hypertrophic cardiomyopathy, a genetic disease affecting the heart muscle. Treatment has long posed challenges for the global medical community. Now, a surgeon at Wuhan's Tongji Hospital is offering a solution.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3